Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Urine-Based Immunoassays Developed for Visceral Leishmaniasis

By LabMedica International staff writers
Posted on 04 Nov 2016
Visceral Leishmaniasis (VL), a severe parasitic disease, and can be fatal if diagnosis and treatment is delayed and diagnostic tests available for VL such as tissue aspiration are invasive and painful although they are capable of evaluating the treatment response.

Post kala-azar dermal leishmaniasis (PKDL), a skin related outcome, is a potential reservoir for the spread of VL and parasitological examination of slit-skin smear along with the clinical symptoms is routinely used for diagnosis of PKDL. More...
Therefore, a noninvasive test with acceptable sensitivity and competency, additionally, to decide cure would be an asset in disease management and control.

Infectious disease specialists at the Indian Institute of Chemical Biology (Kolkata, India) enrolled 186 participants during March 2011 to July 2016. Urine samples of 97 parasitologically proven and rK39-RDT tested VL cases were obtained before the treatment started. Out of 97 VL samples, 18 were acquired for longitudinal study at different time points. Samples were also collected from 75 control subjects and 14 urine samples, which were confirmed by skin biopsy or slit-skin smear were collected from PKDL patients.

The team also performed enzyme-linked immunosorbent assays (ELISA) and the optical densities were read at 492 nm. The scientists also carried out dot blot assays and a nitrocellulose membrane-based dipstick was prepared to have a test and a control line for visual detection of the disease. Like dot blot assay the dipstick test comprises incubation with urine sample followed by enzyme-conjugated anti-human immunoglobulin G (IgG) and then substrate chromogen including washing in each step. Dark brown colored bands both at the test and control line show VL positivity and a single band at the control line infers VL negativity.

The team found that the ELISA and dipstick test were extremely effective for diagnosis of VL and PKDL through urine samples thus, may substitute the existing invasive diagnostics. Utility of these tests as indirect methods of monitoring parasite clearance can define infected versus cured. Urine-based dipstick test is simple, sensitive and above all noninvasive method that may help not only in active VL case detection but also to ascertain treatment response. It can therefore, be deployed widely for interventions in disease management of VL particularly in poor resource settings. The study was published on October 14, 2016, in the journal Public Library of Science Neglected tropical Diseases.

Related Links:
Indian Institute of Chemical Biology



Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Collection and Transport System
PurSafe Plus®
New
Capillary Blood Collection Tube
IMPROMINI M3
New
Clinical Chemistry System
P780
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The VENTANA HER2 (4B5) test is now CE-IVDR approved (Photo courtesy of Roche)

Companion Diagnostic Test Identifies HER2-Ultralow Breast Cancer and Biliary Tract Cancer Patients

Breast cancer is the most common cancer in Europe, with more than 564,000 new cases and 145,000 deaths annually. Metastatic breast cancer is rising in younger populations and remains the leading cause... Read more

Pathology

view channel
Image: An adult fibrosarcoma case report has shown the importance of early diagnosis and targeted therapy (Photo courtesy of Sultana and Sailaja/Oncoscience)

Accurate Pathological Analysis Improves Treatment Outcomes for Adult Fibrosarcoma

Adult fibrosarcoma is a rare and highly aggressive malignancy that develops in connective tissue and often affects the limbs, trunk, or head and neck region. Diagnosis is complex because tumors can mimic... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.